Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
Plos One
|
November 5, 2015
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines
Maricla Galetti, Pier Giorgio Petronini, Claudia Fumarola, et al.
Journal of Medicinal Chemistry
|
February 16, 2010
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion
Caterina Carmi, Andrea Cavazzoni, Stefano Vezzosi, et al.
Biochemical Pharmacology
|
April 6, 2010
Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines
Maricla Galetti, Roberta R Alfieri, Andrea Cavazzoni, et al.
Journal of Leukocyte Biology
|
April 8, 2010
Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration
Maurizio Brigotti, Pier Luigi Tazzari, Elisa Ravanelli, et al.
Plos One
|
October 30, 2013
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification
Silvia La Monica, Cristina Caffarra, Francesca Saccani, et al.
Molecular Cancer
|
June 6, 2014
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Daniele Cretella, Francesca Saccani, Federico Quaini, et al.
The Journal of Physiology
|
July 29, 2006
Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress
Roberta R Alfieri, Mara A Bonelli, Andrea Cavazzoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 2, 2008
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer
Marcello Tiseo, Marzia Capelletti, Giuseppe De Palma, et al.
Molecular Cancer
|
November 25, 2011
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines
Roberta R Alfieri, Maricla Galetti, Stefano Tramonti, et al.
Cancer Letters
|
April 10, 2012
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
Andrea Cavazzoni, Mara A Bonelli, Claudia Fumarola, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
Plos One
|
November 5, 2015
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines
Maricla Galetti, Pier Giorgio Petronini, Claudia Fumarola, et al.
Journal of Medicinal Chemistry
|
February 16, 2010
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion
Caterina Carmi, Andrea Cavazzoni, Stefano Vezzosi, et al.
Biochemical Pharmacology
|
April 6, 2010
Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines
Maricla Galetti, Roberta R Alfieri, Andrea Cavazzoni, et al.
Journal of Leukocyte Biology
|
April 8, 2010
Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration
Maurizio Brigotti, Pier Luigi Tazzari, Elisa Ravanelli, et al.
Plos One
|
October 30, 2013
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification
Silvia La Monica, Cristina Caffarra, Francesca Saccani, et al.
Molecular Cancer
|
June 6, 2014
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Daniele Cretella, Francesca Saccani, Federico Quaini, et al.
The Journal of Physiology
|
July 29, 2006
Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress
Roberta R Alfieri, Mara A Bonelli, Andrea Cavazzoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 2, 2008
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer
Marcello Tiseo, Marzia Capelletti, Giuseppe De Palma, et al.
Molecular Cancer
|
November 25, 2011
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines
Roberta R Alfieri, Maricla Galetti, Stefano Tramonti, et al.
Cancer Letters
|
April 10, 2012
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
Andrea Cavazzoni, Mara A Bonelli, Claudia Fumarola, et al.
Page
of 14